Ezgi Antmen

5PUBLICATIONS
18CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Functional materials
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 20, 2026
Microfluidic T-Chip enables one-step clinical-scale T-cell purification from blood products for CAR T-cell manufacturing.

|Aug 06, 2025
The E3 ligase HECTD4 regulates COX-2-dependent tumor progression and metastasis.

Joanna A Vuille, Cem Tanriover, Ezgi Antmen

|Jul 07, 2025
CDKN1B (p27/kip1) enhances drug-tolerant persister CTCs by restricting polyploidy following mitotic inhibitors.

Elad Horwitz, Taronish D Dubash, Annamaria Szabolcs

|Nov 11, 2021
The role of biomaterials and scaffolds in immune responses in regenerative medicine: macrophage phenotype modulation by biomaterial properties and scaffold architectures.

Ezgi Antmen, Nihal Engin Vrana, Vasif Hasirci

|Apr 18, 2018
Engineered natural and synthetic polymer surfaces induce nuclear deformation in osteosarcoma cells.

Ezgi Antmen, Menekse Ermis, Utkan Demirci

Pageof 1

Frequent Collaborators

2 joint publications

Vasif Hasirci

2 joint publications

Daniel A Haber

1 joint publications

Menekse Ermis

1 joint publications

Johannes Kreuzer